Found 5 matching trials
Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced or Metastatic Clear Cell Renal Cell Carcinoma
PHASE1This is a Phase 1b/2 study of AVB-S6-500 designed to evaluate the safety an...
Location
University of Maryland Greenebaum Comprehensive Cancer Center
Batiraxcept (AVB-S6-500)/Placebo in Combination With Paclitaxel in Patients With Platinum-Resistant Recurrent Ovarian Cancer
PHASE3This is a randomized, double-blind Phase 3 study to compare the efficacy an...
Location
University of South Alabama Mitchell Cancer Institute
AVB-500 (Batiraxcept) in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer
PHASE1The purpose of this study is to determine safety and tolerability of AVB-50...
Location
Multiple Locations
AVB-S6-500 and Durvalumab in Treating Patients With Platinum-Resistant or Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
PHASE1This trial studies the side effects and best dose of AVB-S6-500 when given ...
Location
M D Anderson Cancer Center
Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced Pancreatic Adenocarcinoma
PHASE1This is a Phase 1b/2 study of batiraxcept (AVB-S6-500) designed to evaluate...